well as to various interest groups who become more involved as the budget becomes public. Starting approximately in February 1994, the individual institutes and the NIH central budget office (and OAR) began specific plans (Formulation) for the FY 1996 budget, which will be in effect from October 1995 to September 30, 1996. In addition to dealing with issues directly related to the FY 1994 and FY 1995 budgets, the institute had to consider future budgets in relation to the "NIH Five Year Plan for HIV-Related Research" (the AIDS plan described above), the overall NIH Strategic Plan, and other cross-cutting plans that the individual institute may have had. The multi-year nature of this process is also demonstrated in Figure 5.5, which focuses on the FY 1994 budget planning cycle that began in November of 1991 and governed institute spending through September 30, 1994. (An additional complexity that is not shown in Figure 5.5 is that prior to reorganization, the White House Office on National Drug Control Policy reviewed the drug-related portions of the ADAMHA budget. In addition, the National AIDS Program Office [NAPO] assumed responsibility for reviewing the AIDS budget requests of all PHS agencies beginning in FY 1990.)
With this general overview of the budget process and its complexity in mind, one can now look at the more specific experiences of ADAMHA and NIH budgeting as they relate to AIDS funding.
The budget process for ADAMHA remained relatively stable since FY 1983, when the first funds were appropriated for AIDS